Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(n/a)
# 4,933
Out of 5,147 analysts
22
Total ratings
n/a
Success rate
-35.62%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Equal-Weight | $423 → $350 | $319.38 | +9.59% | 2 | Feb 23, 2026 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,550 → $1,475 | $1,366.69 | +7.92% | 2 | Feb 10, 2026 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $254.34 | +12.05% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $64.51 | +101.52% | 7 | Dec 2, 2025 | |
| DHR Danaher | Initiates: Overweight | $270 | $210.64 | +28.18% | 1 | Dec 2, 2025 | |
| A Agilent Technologies | Initiates: Overweight | $180 | $121.38 | +48.29% | 1 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $344.39 | -22.76% | 8 | Jul 31, 2025 |
Waters
Feb 23, 2026
Maintains: Equal-Weight
Price Target: $423 → $350
Current: $319.38
Upside: +9.59%
Mettler-Toledo International
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $1,550 → $1,475
Current: $1,366.69
Upside: +7.92%
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $254.34
Upside: +12.05%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $64.51
Upside: +101.52%
Danaher
Dec 2, 2025
Initiates: Overweight
Price Target: $270
Current: $210.64
Upside: +28.18%
Agilent Technologies
Dec 2, 2025
Initiates: Overweight
Price Target: $180
Current: $121.38
Upside: +48.29%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $344.39
Upside: -22.76%